Dr. Ann Omachi, MD

NPI: 1780743740
Total Payments
$10,529
2024 Payments
$58.12
Companies
35
Transactions
418
Medicare Patients
1,564
Medicare Billing
$138,804

Payment Breakdown by Category

Food & Beverage$10,510 (99.8%)
Education$19.11 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,510 415 99.8%
Education $19.11 3 0.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,383 87 $0 (2024)
Janssen Pharmaceuticals, Inc $1,640 56 $0 (2021)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,474 56 $0 (2023)
Merck Sharp & Dohme LLC $820.74 37 $0 (2022)
Lilly USA, LLC $628.30 25 $0 (2023)
Novo Nordisk Inc $607.93 30 $0 (2023)
GlaxoSmithKline, LLC. $598.79 24 $0 (2023)
Novartis Pharmaceuticals Corporation $375.59 10 $0 (2019)
PFIZER INC. $349.20 19 $0 (2022)
Amgen Inc. $321.99 10 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $58.12 3 AstraZeneca Pharmaceuticals LP ($37.58)
2023 $443.53 20 AstraZeneca Pharmaceuticals LP ($118.15)
2022 $773.21 37 Boehringer Ingelheim Pharmaceuticals, Inc. ($260.40)
2021 $1,564 78 Boehringer Ingelheim Pharmaceuticals, Inc. ($439.85)
2020 $1,238 56 Janssen Pharmaceuticals, Inc ($354.79)
2019 $2,319 67 AstraZeneca Pharmaceuticals LP ($809.07)
2018 $2,217 80 AstraZeneca Pharmaceuticals LP ($555.74)
2017 $1,916 77 AstraZeneca Pharmaceuticals LP ($467.34)

All Payment Transactions

418 individual payment records from CMS Open Payments — Page 1 of 17

Date Company Product Nature Form Amount Type
02/29/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.70 General
Category: Respiratory
01/24/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $21.88 General
Category: Cardiovascular and Metabolism
01/11/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $20.54 General
Category: Oncology
12/20/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $25.34 General
Category: Cardiovascular and Metabolism
12/14/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $22.40 General
Category: Diabetes
11/30/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $29.15 General
Category: Diabetes
11/15/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $26.24 General
Category: DIABETES
11/01/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX Food and Beverage In-kind items and services $29.26 General
Category: RESPIRATORY
10/12/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $21.01 General
Category: Cardiovascular and Metabolism
09/27/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $26.42 General
Category: Cardio-renal
09/25/2023 Novo Nordisk Inc Rybelsus (Drug) Food and Beverage In-kind items and services $16.26 General
Category: Diabetes
08/31/2023 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $23.49 General
Category: Inhibitor of SGLT2 and SGLT1
07/19/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $21.23 General
Category: DIABETES
06/08/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $24.27 General
Category: Diabetes
06/05/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $14.15 General
Category: Respiratory
05/17/2023 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $21.47 General
Category: VACCINES
05/10/2023 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $19.52 General
Category: Oncology
04/10/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $13.73 General
Category: Respiratory
04/04/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.18 General
Category: Cardiovascular and Metabolism
03/28/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $21.74 General
Category: DIABETES
03/15/2023 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $21.27 General
Category: Diabetes
02/16/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $22.66 General
Category: DIABETES
02/09/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $24.74 General
Category: Cardiovascular and Metabolism
12/01/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $16.64 General
Category: DIABETES
11/18/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $15.28 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 307 435 $91,783 $25,965
2022 8 438 696 $106,221 $40,421
2021 7 404 654 $87,364 $41,480
2020 6 415 721 $84,545 $30,938
Total Patients
1,564
Total Services
2,506
Medicare Billing
$138,804
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 130 241 $51,431 $12,755 24.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 54 69 $21,117 $6,440 30.5%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 61 62 $13,646 $4,689 34.4%
G0008 Administration of influenza virus vaccine Office 2023 62 63 $5,589 $2,081 37.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 174 416 $77,884 $24,521 31.5%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 82 86 $6,289 $6,022 95.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 45 53 $12,971 $3,926 30.3%
G0008 Administration of influenza virus vaccine Office 2022 83 87 $4,301 $3,140 73.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 11 11 $2,365 $1,697 71.7%
G0009 Administration of pneumococcal vaccine Office 2022 16 16 $741.60 $579.76 78.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 15 15 $1,283 $427.45 33.3%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 12 12 $385.92 $108.87 28.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 171 413 $60,464 $25,261 41.8%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2021 76 76 $5,396 $5,049 93.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 34 41 $8,567 $4,151 48.5%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 16 17 $4,724 $2,508 53.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 14 14 $3,200 $2,195 68.6%
G0008 Administration of influenza virus vaccine Office 2021 78 78 $3,741 $1,631 43.6%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 15 15 $1,272 $684.40 53.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 177 478 $66,920 $20,724 31.0%
90662 Vaccine for influenza for injection into muscle Office 2020 92 92 $5,980 $5,610 93.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 21 25 $5,000 $2,040 40.8%
G0008 Administration of influenza virus vaccine Office 2020 97 97 $4,365 $1,996 45.7%
G0009 Administration of pneumococcal vaccine Office 2020 14 14 $630.00 $287.03 45.6%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 14 15 $1,650 $280.73 17.0%

About Dr. Ann Omachi, MD

Dr. Ann Omachi, MD is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780743740.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Omachi, MD has received a total of $10,529 in payments from pharmaceutical and medical device companies, with $58.12 received in 2024. These payments were reported across 418 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($10,510).

As a Medicare-enrolled provider, Omachi has provided services to 1,564 Medicare beneficiaries, totaling 2,506 services with total Medicare billing of $138,804. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Daly City, CA
  • Active Since 12/06/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1780743740

Products in Payments

  • FARXIGA (Drug) $1,595
  • JARDIANCE (Drug) $1,335
  • XARELTO (Drug) $1,087
  • INVOKANA (Drug) $550.29
  • TRULICITY (Drug) $457.65
  • JANUVIA (Drug) $394.21
  • ENTRESTO (Drug) $375.59
  • Ozempic (Drug) $317.68
  • BEVESPI AEROSPHERE (Drug) $260.67
  • STEGLATRO (Drug) $238.04
  • TRELEGY ELLIPTA (Drug) $232.13
  • PREVNAR 13 (Biological) $212.05
  • XIFAXAN (Drug) $201.10
  • Repatha (Biological) $185.97
  • BYDUREON (Drug) $176.84
  • NURTEC ODT (Drug) $151.77
  • FASENRA (Drug) $138.01
  • TRADJENTA (Drug) $132.04
  • NEXLETOL (Drug) $117.93
  • Creon (Drug) $111.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Daly City